Skip to main content

Latest Market News — Page 98

Page 98 · 30 stories scored 7+ · newest 4:35 AM ET · How scores work

Sun, Oct 253 stories
Sat, Oct 2414 stories
7VWAGYVolkswagen AGAudi Pledges $4.2B Georgia Plant Producing 200K SUVs a YearProduct & regulatory · Seeking Alpha▲ Positive7CLYMClimb Bio, Inc.Climb Bio's pMN Drug Shows B-Cell Depletion, Remission at 12 Weeks in Early Phase 2Product & regulatory · Wiseek News▲ Positive8AZNAstraZeneca PLCImfinzi Combo Cuts Bladder Cancer Death Risk 42% in Phase III VOLGA TrialProduct & regulatory · BusinessWire▲ PositivePro8AMGNAMGEN INCImdelltra-Imfinzi Combo Cuts Lung Cancer Death Risk 58% in Phase 3Product & regulatory · Reuters▲ PositivePro8PBLSParabilis Medicines, Inc.Zolucatetide Hits 72% Response Rate in Desmoid Tumors; FDA Aligns on Phase 3Product & regulatory · GlobeNewswire▲ PositivePro7ONCBeOne Medicines Ltd.BeOne's GPC3 Bispecific Hits 36% ORR in Liver Cancer; Registrational Trials Planned by Year-EndProduct & regulatory · BusinessWire▲ Positive8MRNAModerna, Inc.Melanoma Combo Cuts Recurrence Risk ~42% as Analysts Split on ModernaProduct & regulatory · Wiseek News▲ PositivePro7TSLATesla, Inc.Tesla Slashes Capex to $20B as Operating Income Falls 56%Earnings & guidance · Wiseek News▼ Negative7JNJJohnson & JohnsonJ&J Sets Mid-2027 DePuy Spin as $20–22B Orthopedics Valuation Circulates; UK Clears IcotydeM&A & partnerships · Wiseek News● Neutral7OECOrion S.A.Darolutamide Cuts Metastasis or Death Risk 58% in High-Risk Prostate Cancer TrialProduct & regulatory · GlobeNewswire▲ Positive7ZYMEZymeworks Inc.ZW191 Hits 64.5% Response Rate at 6.4 mg/kg With Half the Severe ToxicityProduct & regulatory · Wiseek News▲ Positive7IMTXImmatics N.V.Immatics PRAME Programs Show 32% and 41% Response Rates in Early Solid-Tumor TrialsProduct & regulatory · Wiseek News▲ Positive7AAPLApple Inc.iPhone Duo Sells Out at Launch as Demand Outstrips Tight SupplyProduct & regulatory · Business Line▲ Positive8LAWRRobot Consulting Co., Ltd.Robot Consulting Appeals Nasdaq Delisting, Trading Halt PersistsLegal & risk · ACCESS Newswire▼ NegativePro
Fri, Oct 2313 stories
7ABBVAbbVie Inc.FDA Clears At-Home Subcutaneous SKYRIZI Induction for Crohn's DiseaseProduct & regulatory · dpa-AFX▲ Positive7BABoeing CoBoeing's 777 Freighter Output Stalled Two Months by Supplier DisputeLegal & risk · Reuters▼ Negative7CWLPFCaldwell Partners International Inc.Caldwell Offloads IQTalent for C$4.7M, Cancels 1.45M SharesM&A & partnerships · ACCESS Newswire▲ Positive7XXII22nd Century Group, Inc.22nd Century Registers Up to $18.8M in Shares for Sale as Cash Crunch PersistsFinancing · Reuters▼ Negative7HHHHoward Hughes Holdings Inc.Howard Hughes Holdings Set to Join S&P SmallCap 600 IndexGovernance · Reuters▲ Positive7WULFTeraWulf Inc.TeraWulf Lifts Revolver to $400M, Frees Up $150M LC SublimitFinancing · Reuters▲ Positive8CIRCCircle8 Group, Inc.Lyneer Hit With PEO Default Notice; SPP Claims New Defaults Despite August SettlementLegal & risk · Reuters▼ NegativePro7MASK3 E Network Technology Group LtdMicro-Cap 3 E Network Sets 2-for-1 Share Consolidation After $5M PlacementFinancing · Reuters▼ Negative7ARBBARB IOT Group LtdCEO, Chairman and Director All Depart ARB IOT Effective ImmediatelyExecutive changes · Reuters▼ Negative7FLRFLUOR CORPFluor Unit Wins $2.41B Navy Nuclear Propulsion Contract ModificationM&A & partnerships · Dow Jones Newswires▲ Positive7ELMEElme CommunitiesElme Confirms NYSE Delisting, OTC Trading Starts October 26 as Shares CrashGovernance · Seeking Alpha▼ Negative7MACIMelar Acquisition Corp. IMelar Shares Jump 73% After Hours as Everli SPAC Deal Wins ApprovalM&A & partnerships · Dow Jones Newswires▲ Positive8CRWVCoreWeave, Inc.CoreWeave CDS Blows Past 11% as Neocloud Credit Fears SpreadLegal & risk · Binance News▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.